VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MTNBMatinas BioPharma Holdings, Inc.
$0.63$4M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMTNBPrice History

MTNB logoMatinas BioPharma Holdings, Inc. (MTNB) Stock Price History

Historical prices from 2014 to 2026

$0.63+0.03  (+4.47%)close Jun 22
Returns
1M
+12.9%
3M
+1.5%
YTD
-2.6%
1Y
-32.9%
3Y
-67.9%
5Y
-57.2%
ATH$199.50Mar 2017-99.7%
ATL$0.47Apr 2025pre-split
Avg Vol (50D)182K/ day
52-Week Range$0.48 — $3.09
LowCurrent: $0.63High

Loading 10-year price history...

MTNB Historical Performance

1 YearTotal Return
-32.9%
Price: -32.9%
3 YearsTotal Return
-96.7%
CAGR: -67.9%
Price: -96.7%
5 YearsTotal Return
-98.6%
CAGR: -57.2%
Price: -98.6%
YTD
-2.6%

MTNB Annual Returns

Year-by-year price performance · 2014–2026

Best+272.1%2019
Worst-95.5%2024
Up years3/13
2014-65.4%
2015+88.9%
2016+56.4%
2017-22.1%
2018-52.0%
2019+272.1%
2020-41.1%
2021-42.0%
2022-52.8%
2023-59.4%
2024-95.5%
2025-0.3%
2026-1.9%
2014 annual price return
-65.4%
2015 annual price return
+88.9%
2016 annual price return
+56.4%
2017 annual price return
-22.1%
2018 annual price return
-52.0%
2019 annual price return
+272.1%
2020 annual price return
-41.1%
2021 annual price return
-42.0%
2022 annual price return
-52.8%
2023 annual price return
-59.4%
2024 annual price return
-95.5%
2025 annual price return
-0.3%
2026 annual price return
-1.9%
LessMore
Alpha vs S&P 500
1Y-57.9%
3Y-85.7%
5Y-68.5%

Price returns only.

Download Historical Data

2,999 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

MTNB Stock Price Trajectory (2014–2026)

As of June 23, 2026, Matinas BioPharma Holdings, Inc. (MTNB) trades at $0.63, representing a -32.9% return over the past year. The stock has delivered a -98.6% total return over five years (-57.2% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $199.50 on March 2, 2017. From this peak, MTNB has corrected -99.7%, currently trading 31% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ARQT (+91.7% 1Y), NKTR (+608.2% 1Y), and PRAX (+557.0% 1Y), MTNB has underperformed the peer group average. Compare MTNB vs ARQT →

MTNB Historical Price Data · from 2014

Rows 1–50 of 2,999
Date Open High Low Close Volume Change %
2026-06-220.600.670.600.6327K+4.47%
2026-06-180.710.720.600.6048K-14.93%
2026-06-170.710.730.650.71103K-1.39%
2026-06-160.750.800.720.72104K-3.25%
2026-06-150.790.790.740.7439K-4.59%
2026-06-120.790.830.760.7827K-3.87%
2026-06-110.840.840.780.8136K+2.06%
2026-06-100.770.820.700.8050K-0.21%
2026-06-090.820.860.760.80103K-4.01%
2026-06-080.780.830.720.8388K+9.18%
2026-06-050.780.790.760.7623K-4.98%
2026-06-040.780.810.760.8011K+2.83%
2026-06-030.800.810.740.7890K-3.05%
2026-06-020.880.880.790.80196K-7.97%
2026-06-010.810.880.780.87141K+7.65%
2026-05-290.750.830.750.8140K+1.95%
2026-05-280.700.850.700.7957K+8.76%
2026-05-270.710.740.710.7334K+0.34%
2026-05-260.660.790.650.73110K+3.39%
2026-05-220.650.710.630.7042K+5.11%
2026-05-210.590.670.580.6796K+5.02%
2026-05-200.480.640.480.64312K+14.52%
2026-05-190.550.750.480.566.25M+4.11%
2026-05-180.530.590.530.5441K-7.76%
2026-05-150.560.600.560.5839K+1.38%
2026-05-140.570.580.560.5712K+1.44%
2026-05-130.570.590.560.5636K-6.11%
2026-05-120.630.640.600.6075K-6.17%
2026-05-110.610.670.600.6426K+0.42%
2026-05-080.560.640.560.6414K-2.40%
2026-05-070.660.670.640.6516K-3.94%
2026-05-060.660.700.660.6844K+1.40%
2026-05-050.680.700.650.6721K+0.09%
2026-05-040.700.700.670.6717K-4.15%
2026-05-010.690.700.640.7033K+7.47%
2026-04-300.630.670.580.6556K+4.89%
2026-04-290.600.620.590.6232K+0.10%
2026-04-280.600.610.600.626K+1.56%
2026-04-270.570.620.570.6122K0.00%
2026-04-240.620.620.600.6122K+0.66%
2026-04-230.580.630.570.6165K+8.18%
2026-04-220.560.570.560.5619K+1.84%
2026-04-210.560.570.550.5530K+0.20%
2026-04-200.490.560.490.5579K+9.80%
2026-04-170.530.540.500.5020K-4.76%
2026-04-160.530.530.490.5337K0.00%
2026-04-150.510.540.500.5333K-0.76%
2026-04-140.490.530.490.53114K+5.17%
2026-04-130.520.530.500.506K+0.60%
2026-04-100.540.540.500.5015K-0.97%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MTNB — Frequently Asked Questions

Quick answers to the most common questions about buying MTNB stock.

How has MTNB stock performed recently?

MTNB declined -32.9% over the past year, below its 5-year annualized CAGR of -57.2%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is MTNB's all-time high price?

Matinas BioPharma Holdings, Inc. reached $199.50 on 2017-03-02. The 52-week high is $3.09. Current 1-year return of -32.9% places the stock further from historical peaks.

Where can I download MTNB historical price data?

This page provides MTNB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

501 data points · sampled from 2,999